<p><span style="font-size: 8pt;font-family: Arial;">The Fund seeks to achieve long term capital growth. The Fund invests at least 80% of its total assets in equity securities and equity-related securities (namely American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs)) of companies domiciled in, or exercising a significant part of their economic activity in, global developed markets. Investment decisions are based on company-specific research to identify and select equity securities that, in the opinion of the Investment Adviser, have a viable competitive advantage and the potential to produce attractive long-term capital growth. The Fund’s portfolio is expected to be concentrated (i.e. it is expected to hold relatively few stocks in comparison to other funds), but there is no guarantee that this will always be the case.</span></p>


BlackRock (Luxembourg) SA

BlackRock Investment Management (UK) Ltd.

Other Equity

Equity

MSCI World NR EUR

BGF Global Unconstrained Eq A2 SGD H Acc

BGF Global Unconstrained Eq SI2 USD Acc

2024

2023

2022

2021

2020

United States

Netherlands

Denmark

Unclassified

Technology

Financial Services

Healthcare

Communication Services

Microsoft Corp

ASML Holding NV

Meta Platforms Inc Class A

Novo Nordisk AS Class B

S&P Global Inc

Mastercard Inc Class A

Visa Inc Class A

Alphabet Inc Class C

Thermo Fisher Scientific Inc

Masimo Corp